AIM ImmunoTech Inc
Change company Symbol lookup
Select an option...
AIM AIM ImmunoTech Inc
PBYA Probility Media Corp
RA Brookfield Real Assets Income Fund Inc.
PAA Plains All American Pipeline LP
$ESDOWD DOW JONES SPAIN STK US$ NDX
GOOGL Alphabet Inc
WFC Wells Fargo & Co
BAC Bank of America Corp
BA Boeing Co
WMT WALMART STORES INC
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

AIM ImmunoTech Inc., formerly Hemispherx Biopharma, Inc., is a specialty pharmaceutical company. The Company is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company's segment is engaged in research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon. The Company's products include Alferon N Injection and Ampligen. Alferon N Injection is approved for the use in intralesional treatment of refractory or recurring external genital warts in patients of over 18 years of age. Ampligen is a drug undergoing clinical development for the treatment of Chronic Fatigue Syndrome (CFS). Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) is a low-dose, oral liquid formulation of natural alpha interferon. Alferon LDO is a liquid natural interferon for oral administration.

Closing Price
$2.43
Day's Change
-0.01 (-0.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.44
Day's Low
2.36
Volume
(Light)
Volume:
1,811,329

10-day average volume:
3,966,092
1,811,329
  • Prev Close
    2.44
  • Today's Open
    2.40
  • Day's Range
    2.36-2.44
  • Avg Vol (10-day)
    4.0M
  • Last (time)
    8:00p ET 07/02/20
  • Last (size)
    455
  • 52-Wk Range
    0.381 - 7.11
    LowHigh
  • (11/26/19 - 03/09/20)
    537.80%
  • 186.4%
  • Market Cap
    79.3M
  • Shares Outstanding
    32.6M
  • -2.55
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -0.9
  • 1.46
  • (% of float 06/15/20)
    6.20

Latest News

June 29, 2020
6:55 am ET
Accesswire
June 26, 2020
9:31 am ET
PR Newswire
June 15, 2020
8:00 am ET
Accesswire
June 11, 2020
9:05 am ET
Accesswire
May 29, 2020
9:31 am ET
PR Newswire
May 14, 2020
11:11 am ET
PR Newswire
6:50 am ET
Accesswire
April 29, 2020
6:30 am ET
Accesswire
April 20, 2020
6:31 am ET
Accesswire
April 06, 2020
11:29 pm ET
Accesswire
1:00 pm ET
Accesswire
6:30 am ET
Accesswire
March 10, 2020
8:14 am ET
MarketWatch
March 08, 2020
11:34 am ET
MarketWatch
March 04, 2020
2:01 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.